ATB Therapeutics is a preclinical biotech developing targeted oncology therapies with recombinant molecules combining an antibody, linker, and payload, supported by a strong proprietary platform.

About

Related news

News

Learn more
3107dad4-7ae7-4171-83e5-869326da68a6

ATB Therapeutics Announces Appointment of Dr. Torsten Dreier as Chief Development Officer and Opening of New R&D Hub in Gent

    Press release

10.06.2025

Related jobs

Jobs

Learn more

Senior Scientist Molecular Biology

Ghent | Fixed contract - Full time | Research & development